These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18679116)

  • 1. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
    Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
    Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
    Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Łukasiak J; Saba V; Scalise G
    J Infect Dis; 2005 Nov; 192(9):1613-20. PubMed ID: 16206076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
    Cirioni O; Silvestri C; Ghiselli R; Giacometti A; Orlando F; Mocchegiani F; Chiodi L; Vittoria AD; Saba V; Scalise G
    Peptides; 2006 Nov; 27(11):2600-6. PubMed ID: 16797106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
    Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
    J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice.
    Oz N; Agalar C; Daphan CE; Agalar F; Turkyilmaz R
    Int J Surg Investig; 2001; 2(5):347-52. PubMed ID: 12678538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
    Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Gabrielli E; Mocchegiani F; Cianforlini N; Trombettoni MM; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2009 Apr; 37(4):1403-7. PubMed ID: 19318826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.
    Ghiselli R; Cirioni O; Giacometti A; Scalise A; Simonetti O; Mocchegiani F; Orlando F; Goteri G; Della Vittoria A; Filosa A; Silvestri C; Offidani A; Bertani A; Scalise G; Saba V
    J Surg Res; 2008 Jan; 144(1):74-81. PubMed ID: 17574587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds.
    Simonetti O; Cirioni O; Ghiselli R; Goteri G; Orlando F; Monfregola L; De Luca S; Zizzi A; Silvestri C; Veglia G; Giacometti A; Guerrieri M; Offidani A; Scaloni A
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3047-55. PubMed ID: 22729599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
    J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Bergnach C; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Skerlavaj B; Saba V; Zanetti M; Scalise G
    Crit Care Med; 2004 Dec; 32(12):2485-90. PubMed ID: 15599155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
    Cirioni O; Ghiselli R; Tomasinsig L; Orlando F; Silvestri C; Skerlavaj B; Riva A; Rocchi M; Saba V; Zanetti M; Scalise G; Giacometti A
    Shock; 2008 Oct; 30(4):443-8. PubMed ID: 18391859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cornuside on experimental sepsis.
    Jiang WL; Chen XG; Zhu HB; Tian JW
    Planta Med; 2009 May; 75(6):614-9. PubMed ID: 19263342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
    J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
    Simonetti O; Cirioni O; Goteri G; Ghiselli R; Kamysz W; Kamysz E; Silvestri C; Orlando F; Barucca C; Scalise A; Saba V; Scalise G; Giacometti A; Offidani A
    Peptides; 2008 Apr; 29(4):520-8. PubMed ID: 18255189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.